Join our mailing list!
(Your shopping cart is empty)
Diane Publishing Books
Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes
Luigi Marchionni (au)
Assesses the evidence that three marketed gene expression-based assays improve prognostic accuracy, treatment choice, and health outcomes in women diagnosed with early stage breast cancer. Three gene expression assays were evaluated; Oncotype DX™, MammaPrint® and the Breast Cancer Profiling (BCP or H/I ratio) test, and for gene expression signatures underlying the assays. They sought evidence on: analytic performance of tests; clinical validity; clinical utility; harms; and impact on clinical decision making and health care costs. Conclusions: Oncotype DX is furthest along the validation pathway, with retrospective evidence that it predicts distant spread and chemotherapy benefit to a clinically relevant extent over standard predictors. Illus.
War of the Rebellion: Official Records of the Union & Confederate Armies: Series I, Volume I
Arizona Wetlands & Waterfowl
American Short Story, 1945-1980: A Critical History
Lamborghini: Supercar Supreme
Not Fade Away: The On-Line World Remembers Jerry Garcia
Share your knowledge of this product with other customers...
Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
Become an Affiliate
Send Us Feedback
Copyright ï¿½ 2004 Diane Publishing Company. All Rights Reserved.